Burjeel Holding offers in Davos health care solutions to counter climate change

Burjeel Holding, a leader in the field of specialized health care in the Middle East and North Africa region, participated in the World Economic Forum in Davos, where she reviewed her initiatives that combine climate change considerations and provide advanced health care services, with a focus on developable solutions in the field of cancer control.

In a high -level round table entitled “Investing in Health Care: A recipe for steadfastness in the face of climate change?”, Dr. Shamshir Fayalil, founder and chairman of Bergel Holding, joined international leaders to discuss the most prominent urgent health challenges.

The session discussed the main obstacles facing the health sector and ways to overcome them, while highlighting the transformative opportunities to develop and finance innovative health solutions that keep pace with the future affected by climate change, and the participants also reviewed how cooperation between different parties and directed investment can contribute to building a proactive and flexible approach that enhances global health in The effects of climate change remained.

Burjeel initiatives in promoting sustainable health care to counter climate change
Dr. Shamsheer Fayalil stressed that the initial investment in climate change health care may require significant resources, but long -term returns play a decisive role in global health protection, and highlighted the “Burjish Climate and Health Center”, an innovative initiative aimed at providing integrated solutions to confront Climate change, by integrating climate consultations and preventive strategies directly into clinical care.

The center was highlighted in a white paper issued by the World Economic Forum entitled “Healthcare in a variable climate: investment in flexible solutions”, where the center’s role was highlighted in providing advanced examination of influential environmental factors such as air pollution and high temperatures.

Facing the effects of climate change on health
Dr. Shamsheer explained that Burjeel Holding seeks to play a pre -emptive role in facing the health effects caused by climate change. “We have created a specialized team within our climate and health center to develop a new health care model that fits climate challenges,” he said.

Dr. Shamshir also announced the launch of an innovative program next summer that depends on artificial intelligence to communicate with patients at risk, who were identified through doctors or electronic medical records, with the aim of alerting them to acute climate changes and their impact on their health.

The session witnessed the participation of a number of prominent personalities, including Dr. Aurzio Skilache, Italian Minister of Health, Nick Stoder from Oliver and Iman, Alan Dangor of the Wilcum Foundation, and Audrey Duffal from Sanovi. Camilla Macappily Languel also participated in Mubadala, Mads Kruggdard Tomsen of Novo Nordisk, Bam Cheng from Astrazenica, and Peter Sands from the World Fund, and the session was moderated by Dr. Victor Dzao of the National Academy of Medicine.

Innovation in caring for cancer patients: Bring the gap between local solutions
During the 2025 annual meeting, Bergel Holding also conducted an approved workshop from the World Economic Forum entitled “Innovation in Cancer Care: Blocking the Gap between Local Solutions”, and the session gathered many stakeholders who have a common interest in improving care for cancer patients in emerging markets, The interactive workshop was held for global experts led by Richard Louis, presenter of the MSNBC, Professor Khaled Muslim, Professor Don Dison, and Professor Gracem Boyce.

Discussions focused on exploiting emerging techniques to improve cancer diagnosis and enhance access to treatment at lower costs. Experts discussed strategies to expand the scope of successful local solutions, especially in emerging markets, with the aim of providing a fair global treatment for cancer. They also discussed the importance of encouraging emerging economies to use their limited resources effectively to create clinics and hospitals. The role of external financing agencies was emphasized in supporting these efforts by providing modern medical technologies to provide sustainable services in the most deprived areas.

In this context, Professor Khaled Muslim, Head of Research Department at the Bergel Holding Group, indicated that “the absence of harmony between countries in the paths of organizational approval is a major challenge to bring clinical experiences to emerging markets.” He explained that the long periods of separation between clinical trials and marketing licensing, which often depend on American or European approvals, hinder access to innovative drugs, and added: “Adopting uniform standards that meet the needs of the pharmaceutical industry and ensure the continuity of providing new treatments can make a big difference, as The establishment of cooperative groups with experimental capabilities for decentralization will contribute to accelerating the registration in appropriate quantities in line with the urgent needs of global experiences. “